Coverage of cervical cytopathological examination among women from Southern Brazil: prevalence rates and associated factors
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2021.171620Keywords:
Papanicolaou Test, Mass Screening, Women’s Health, Epidemiology, Secondary PreventionAbstract
Objective: To determine the coverage of cervical cancer screening and its associated factors among women from southern Brazil aged 25 to 64 years. Methods: This was a cross-sectional population-based study conducted in the city of Rio Grande, RS. The outcome of interest consisted of a cytopathological examination of the uterine cervix in the previous three years in women aged 25 to 64 years, according to the criteria of the Brazilian National Cancer Institute. The data were collected in 2016, and the following independent variables were considered: age, skin color, marital status, schooling, socioeconomic status, gestational history, smoking habits, overweight, health insurance, having visited a physician or having been visited by a community health agent in the previous year, and household registered in a primary care facility (PCF) of the healthcare system. Results: This study included a total of 521 women, with a mean age of 44.3 years. The coverage of cervical cancer screening was 78.1% (95% CI: 73.5 to 82.7). The following characteristics were associated with the outcome: marital status, non-smoking habits, health insurance, having visited a physician in the previous year, and household registered in a PCF. Conclusion: The coverage of cervical cancer screening observed in our study (8 out of ten women) was close to the Brazilian Ministry of Health goals. Single women, smoking habits, no health insurance, having not visited a physician in the previous year, and not having their household registered in a PCF were considered risk factors.
Downloads
References
Arrossi S, Ramos S, Paolino M, Sankaranarayanan R. Social inequality in Pap smear coverage: identifying under-users of cervical câncer screening in Argentina. Reproductive Health Matters. 2008; 16(32): 50-8
Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities. PLoS Med. 2008; 5(6): e132. https://doi.org/10.1371/journal.pmed.0050132.
Barbosa IR. Regional and Socioeconomic Differences in the Coverage of the Papanicolau Test in Brazil: Data from the Brazilian Health Survey 2013. Rev Bras Ginecol Obstet. 2017; 39: 480-87. https://doi.org/10.1055/s-0037-1604481.
Martins LFL, Thuler LCS, Valente JG. Cobertura do exame de Papanicolau no Brasil e seus fatores determinantes: uma revisão sistemática da literatura. Rev Bras Ginecol Obstet. 2005; 27(8): 485-92.
WHO (World Health Organization). Comprehensive cervical cancer control: a guide to essential practice – 2nd ed. Geneva; 2014.
Yang BH, Bray FI, Parkin DM, Sellors JW, Zhang ZF. Cervical Cancer as a Priority for Prevention in Different World Regions: an evaluation using years of life lost. Int. J. Cancer. 2004; 109(3): 418-24. https://doi.org/10.1002/ijc.11719.
World Health Organization. Early diagnosis and screening: Cervical Cancer [Online]. 2019 [acessado em 10 fev 2019]. Disponível em: http://www.who.int/cancer/prevention/diagnosis-screening/breast-cancer/en/
Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2018: incidência de câncer no Brasil. Coordenação de Prevenção e Vigilância. Rio de Janeiro; 2017.
American Cancer Society. Cancer Facts & Figures 2018. Atlanta, Ga; 2018.
Instituto Nacional de Câncer José Alencar Gomes da Silva. Diretrizes brasileiras para o rastreamento do câncer do colo do útero. Coordenação de Prevenção e Vigilância. Divisão de Detecção Precoce e Apoio a Organização de Rede. 2. ed. Rio de Janeiro; 2016.
The European Union. Cancer Screening in the European Union (2017): Report on the implementation of the Council Recommendation on cancer screening. Lyon; 2017
Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB. Accuracy of the Papanicolau Test in Screening for and Follow-up of Cervical Cytologic Abnormalities: A Systematic Review. Ann Intern Med. 2000; 132: 810-19.
Ng M, Fullman N, Dieleman JL, Flaxman AD, Murray CJL, Lim SS. Effective Coverage: A Metric for Monitoring Universal Health Coverage. PLoS Med. 2014; 11(9): e1001730. https://doi.org/10.1371/journal.pmed.1001730
Dumith SC, Paulitsch RG, Carpena MX, Muraro MFR, Simões MO, Machado KP, Dias MS, Kretschmer AC, Oliz MM, Pontes LS, Susin LRO. Planejamento e execução de um inquérito populacional de saúde por meio de consórcio de pesquisa multidisciplinar. Sci Med. 2018; 28(3): ID30407. https://doi.org/10.15448/1980-6108.2018.3.30407
Malta DC, da Silva Jr JB. O plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis no Brasil e a definição das metas globais para o enfrentamento dessas doenças até 2025: uma revisão. Epidemiol. Serv. Saúde. 2013; 22(1) :151-64. http://dx.doi.org/10.5123/S1679-49742013000100016.
Oliveira MM, Andrade SSCA, Oliveira PPV, Azevedo e Silva G, Silva MMA, Malta DC. Pap-test coverage in women aged 25 to 64 years old, according to the National Health Survey and the Surveillance System for Risk and Protective Factors for Chronic Disease by Telephone Survey, 2013. Rev Bras Epidemiol. 2018; 21: E180014. https://doi.org/10.1590/1980-549720180014.
Xavier TV, Zibetti WB, Capilheira MF. Prevalência da realização do exame citopatológico do colo uterino, no Brasil, nos anos de 2007 e 2013. Rev Med (São Paulo). 2016; 95(2): 66-70. http://dx.doi.org/10.11606/issn.1679-9836.v.95i2p66-70.
Douglas E, Waller J, Duffy SW, Wardle J. Socioeconomic inequalities in breast and cervical screening coverage in England: are we closing the gap? J Med Screen. 2016; 23(2): 98-103. https://doi.org/10.1177/0969141315600192.
US Department of Health and Human Services/Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report: Surveillance for Health Care and Health Survice Use, Adults Aged 18-64 years – Behavioral Risk Factor Surveillance System, United States, 2014; 2017.
Carlotto K, Cesar JA, Hackenhaar AA, Ribeiro PRP. Características reprodutivas e utilização de serviços preventivos em saúde por mulheres em idade fértil: resultados de dois estudos transversais de base populacional no extremo Sul do Brasil. Cad. Saúde Pública. 2008; 24(9): 2054-62. https://doi.org/10.1590/S0102-311X2008000900011.
Mukem S, Meng Q, Sriplung H, Tangcharoensathien V. Low coverage and disparities of breast and cervical cancer screening in Thai women: analysis of National Representative Household Surveys. Asian Pac J Cancer Prev. 2015; 16(18): 8541-51. http://dx.doi.org/10.7314/APJCP.2015.16.18.8541.
Gasperin SI, Boing AF, Kupek E. Cobertura e fatores associados à realização do exame de detecção do câncer de colo de útero em área urbana no Sul do Brasil: estude de base populacional. Cad. Saúde. Pública. 2011; 27(7): 1312-22. https://doi.org/10.1590/S0102-311X2011000700007.
Gelibo T, Roets L, Getachew T, Bekele A. Coverage and Factors Associated with Cervical Cancer Screening: Results from a Population-Based WHO Steps Study in Ethiopia. J Oncol Res Treat. 2017; 2(1): 115.
Simoes EJ, Neschaffer CJ, Hagdrup N, Ali-Abarghoui F, Tao X, Mack N, Brownson RC. Predictors of compliance with recommended cervical cancer screening schedule: a population-based study. J Community Health. 1999; 24(2): 115-30. https://doi.org/10.1023/a:1018754307718.
Coughlin SS, Uhler RJ, Hall HI, Briss PA. Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk? Prev Chronic Dis. 2004; 1(1): A04.
MacLaughlan SD, Lachance JA, Gjelsvik A. Correlation between smoking status an cervical cancer screening: a cross-sectional study. J Low Genit Tract Dis. 2011; 15(2): 114-9. https://doi.org/10.1097/LGT.0b013e3181f58d0d.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Kevin Francisco Durigon Meneghini, Arnildo Agostinho Hackenhaar, Samuel Carvalho Dumith
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
Funding data
-
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
Grant numbers 16/2551-0000359-9
